Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1133166

registered interest
date	19/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether patients whose prescription for a cannabis-based medical product is blocked by an NHS trust can appeal that decision.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	266861
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>In line with routine clinical practice patients wishing to seek a second opinion will be supported to do so. In the first instance clinicians should refer patients for a second opinion using their established protocols. If it is not possible to obtain a second or further opinion using established protocols then National Health Service trusts are instructed to contact their NHS England Regional Medical Director who will be able to offer further advice around a referral route. The NHS England Regional Medical Directors will support NHS trusts in identifying a suitable NHS specialist for a second opinion. Processes may differ in Scotland, Wales and Northern Ireland.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 27/06/2019 12:42:09 answering member 4455 label Biography information for Seema Kennedy
tabling member	4623 label Biography information for Tonia Antoniazzi

1133167

registered interest
date	19/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions his Department has had with (a) NHS England, (b) drug manufacturers and (c) the National Institute for Health and Care Excellence on funding for licensed cannabis-based products.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	266862
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>The Department is in regular contact with the National Institute for Health and Care Excellence (NICE) and NHS England colleagues about a range of issues and has not met with drug manufacturers on funding of licensed cannabis-based products.</p><p>Sativex is currently the only licensed cannabis-based product available in the United Kingdom. NICE considered the clinical and cost effectiveness of Sativex in the development of its clinical guideline on the management of multiple sclerosis published in 2014. NICE was not able to recommend Sativex as a cost-effective use of NHS resources for the treatment of spasticity in people with multiple sclerosis. Sativex is not therefore routinely funded by the NHS in England for use in the treatment of multiple sclerosis, although clinicians are able to make a request for exceptional funding for individual patients who they think may benefit from treatment.</p><p>NICE has been asked to develop clinical guidelines on cannabis-based products for medicinal use and is expected to look at the clinical and cost effectiveness of treatments, including Sativex, as part of this work. This is expected to be published by October 2019.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 27/06/2019 12:43:17 answering member 4455 label Biography information for Seema Kennedy
tabling member	4623 label Biography information for Tonia Antoniazzi

1132764

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	What progress the Government has made on making medical cannabis available to people who need it.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	911421
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The Government acted swiftly to change the law and those patients for whom it is clinically appropriate can be prescribed medicinal cannabis. It is a clinical decision whether to prescribe, and prescriptions of medicinal cannabis are available, and being issued where it is judged clinically appropriate for the patient.</p><p /><p /> answering member constituency West Suffolk answering member printed Matt Hancock question first answered 18/06/2019 16:50:49 answering member 4070 label Biography information for Matt Hancock
tabling member	4623 label Biography information for Tonia Antoniazzi

1037890

registered interest
date	08/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS prescriptions have been issued for patients to use medical cannabis since 1 November 2018.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	206441
answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p><p> </p><p>The Department has made no estimate of future demand for medical cannabis over the next 12 months.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206442 206443 question first answered 16/01/2019 15:13:41 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

1037900

registered interest
date	08/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS prescriptions for medicinal cannabis have been dispensed at a pharmacy since 1 November 2018.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	206442
answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p><p> </p><p>The Department has made no estimate of future demand for medical cannabis over the next 12 months.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206441 206443 question first answered 16/01/2019 15:13:41 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

1037901

registered interest
date	08/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of (a) prescriptions of and (b) patients who will use medical cannabis in the next 12 months.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	206443
answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p><p> </p><p>The Department has made no estimate of future demand for medical cannabis over the next 12 months.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206441 206442 question first answered 16/01/2019 15:13:41 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

1003743

registered interest
date	09/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the (a) knowledge and (b) awareness among GPs of the benefits of medicinal cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	189815
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>The Government has rescheduled cannabis-based products for medicinal use from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001. Doctors on the specialist register of the General Medical Council may now prescribe these products where there might be potential benefit to individual patients. General practitioners will not be able to prescribe but the Government has commissioned the National Institute for Health and Care Excellence to produce guidance for all clinicians by October 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 11:38:40 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

946807

registered interest
date	23/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, with reference to the recommendation of the Advisory Council on the Misuse of Drugs that medicinal cannabis products be moved out of Schedule 1 and into Schedule 2 of the Misuse of Drugs Regulations, how long it will take to reclassify the medicinal cannabis oil used by Alfie Dingley and Billy Caldwell; and whether he plans to ensure that all patients who might benefit from such treatment will be able to access medicinal cannabis by the time the House returns from its summer recess.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	167359
answer	answer is ministerial correction date of answer 07/09/2018 answer text <p>Following the short term ACMD advice, the Home Secretary has confirmed that cannabis-derived medicinal products will be rescheduled. This means that senior clinicians will be able to prescribe the medicines to patients with an exceptional clinical need.</p><p>The Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency will now develop a clear definition of what constitutes a cannabis-derived medicinal product. Only products meeting this definition will be rescheduled. Other forms of cannabis will be kept under strict controls and will not be available on prescription. We will provide more details about this definition and the kinds of products that will be covered in due course.</p><p>The Home Secretary has been clear that speed is of the essence and the products will be available on prescription in the autumn.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 07/09/2018 18:35:25 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi